InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Thursday, 02/05/2015 10:53:56 PM

Thursday, February 05, 2015 10:53:56 PM

Post# of 80868
Musclepharm is not a stock that should be priced below $10-14 price range.

Even if Musclepharm losses a little bit now, down the road it is in a growing sector and it will do just fine.

There is nothing that will stop the protein movement and Musclepharm is part of that movement quite strongly, better than Glanbia, better than MuscleTech and better than Cellucor in terms of branding.

Brad doesn't want to disappoint his stakeholders, so he will change and become more likable from a shareholder's standpoint. Something definitely gotta give with the stock hitting the bottom again with $7, that is almost a drop of 50% from last time Brad endorsed the stock, buying at $13.60

Musclepharm needs to do something better next time and stop delaying announcements that contain less encouraging information. Keeping investors in the dark is not the right thing to do.